- Home
- CTSO vs LPTH Comparison
CTSO vs LPTH Comparison
Compare CTSO & LPTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CTSO
- LPTH
- Stock Information
- Founded
- CTSO 1997
- LPTH 1985
- Country
- CTSO United States
- LPTH United States
- Employees
- CTSO N/A
- LPTH N/A
- Industry
- CTSO Medical/Dental Instruments
- LPTH Semiconductors
- Sector
- CTSO Health Care
- LPTH Technology
- Exchange
- CTSO Nasdaq
- LPTH Nasdaq
- Market Cap
- CTSO 68.2M
- LPTH 81.1M
- IPO Year
- CTSO N/A
- LPTH 1996
- Fundamental
- Price
- CTSO $0.87
- LPTH $2.44
- Analyst Decision
- CTSO Strong Buy
- LPTH Strong Buy
- Analyst Count
- CTSO 3
- LPTH 3
- Target Price
- CTSO $4.67
- LPTH $4.67
- AVG Volume (30 Days)
- CTSO 138.6K
- LPTH 102.8K
- Earning Date
- CTSO 05-14-2025
- LPTH 05-15-2025
- Dividend Yield
- CTSO N/A
- LPTH N/A
- EPS Growth
- CTSO N/A
- LPTH N/A
- EPS
- CTSO N/A
- LPTH N/A
- Revenue
- CTSO $35,594,520.00
- LPTH $32,158,517.00
- Revenue This Year
- CTSO $18.72
- LPTH $16.90
- Revenue Next Year
- CTSO $19.75
- LPTH $52.77
- P/E Ratio
- CTSO N/A
- LPTH N/A
- Revenue Growth
- CTSO 14.51
- LPTH N/A
- 52 Week Low
- CTSO $0.70
- LPTH $1.04
- 52 Week High
- CTSO $1.61
- LPTH $4.42
- Technical
- Relative Strength Index (RSI)
- CTSO 34.05
- LPTH 60.73
- Support Level
- CTSO $0.87
- LPTH $2.27
- Resistance Level
- CTSO $1.16
- LPTH $2.55
- Average True Range (ATR)
- CTSO 0.06
- LPTH 0.16
- MACD
- CTSO -0.02
- LPTH 0.03
- Stochastic Oscillator
- CTSO 0.34
- LPTH 83.08
About CTSO Cytosorbents Corporation
CytoSorbents Corp specializes in treating life-threatening conditions in intensive care and cardiac surgery using proprietary polymer adsorption technology. Its flagship product, CytoSorb, is approved in the EU as an extracorporeal cytokine absorber, aiming to reduce inflammation and prevent multiple organ failure in critical illnesses like sepsis and trauma. Revenue primarily comes from product sales in Germany, with additional income from grant agencies in the United States. The company operates through Direct sales and Distributors/strategic partners in United States, Germany and Other Countries. The company's product consists of Cytosorb, ECOS-300CY, VetResQ, HemoDefend, and DrugSorb-ATR.
About LPTH LightPath Technologies Inc.
LightPath Technologies Inc is a manufacturer, distributor, and integrator of proprietary optical components and assemblies. It is also engaged in the research and development for optical solutions for the traditional optics markets and communications markets. The company's business based on the following product groups: precision molded optics, specialty products, and infrared products. It currently serves the following major markets, distribution and catalog, laser, industrial, instrumentation, telecommunications, and defense.